Why is breyna so expensive?

“Breyna” (often refers to Airsupra/budesonide/formoterol?—brand names vary by country) is usually expensive for a few common industry reasons:

1. Brand-name pricing / lack of generic competition

   • If there isn’t a widely available generic or biosimilar version where you live, the manufacturer can set higher prices.

2. Insurance and pharmacy reimbursement dynamics

   • List price (what the company sets) can be much higher than what insurers/hospitals actually pay, and what you pay depends on your plan’s formulary rules, copays, deductibles, and whether prior authorization is required.

3. Manufacturing and supply costs

   • Inhaled medicines (especially combination inhalers) can be more expensive to manufacture and distribute due to device design, specialized packaging, and stringent quality control.

4. Patent/market exclusivity

   • If the product is still under patent protection or market exclusivity, competitors can’t copy it, keeping prices higher.

5. Limited alternatives for the exact formulation/device

   • Even when “similar” inhalers exist, your specific medication may be chosen because of its dose, delivery device, or clinical fit—so swapping isn’t always straightforward.

If you tell me your country and the exact spelling of the medicine on your box (and the strength), I can be more specific. Also, if you share what you’re paying (e.g., $/month) and whether you have insurance, I can suggest practical ways to reduce the cost (generic equivalents, patient assistance, copay cards, formulary options, or therapeutic alternatives).